Long-term administration of estrogen or tamoxifen to ovariectomized rats affords neuroprotection to hippocampal neurons by modulating the expression of Bcl-2 and Bax

Brain Research

Volumn 1204, Issue , 2008, Pages 1-15

  Sharma, K ^a   Mehra, Raj D ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

17 estradiol; Bcl 2 Bax ratio; Hippocampus; Long term therapy; Tamoxifen

Indexed keywords

ESTROGEN; PROTEIN BAX; PROTEIN BCL 2; SESAME SEED OIL; TAMOXIFEN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DEGENERATIVE DISEASE; DOWN REGULATION; FEMALE; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; LONG TERM CARE; NERVE CELL PLASTICITY; NEUROPROTECTION; NICK END LABELING; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; TREATMENT DURATION; UPREGULATION; WESTERN BLOTTING;

ANIMALS; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; CELL COUNT; ESTROGEN ANTAGONISTS; ESTROGENS; FEMALE; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MICROSCOPY, CONFOCAL; NEURONS; NEUROPROTECTIVE AGENTS; OVARIECTOMY; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, WISTAR; TAMOXIFEN;

ANIMALIA; RATTUS; SESAMUM INDICUM;

EID: 41549137723     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2008.01.080     Document Type: Article

References (66)

1. Almeida O.F., Conde G.L., Crochemore C., Demeneix B.A., Fischer D., Hassan A.H., Meyer M., Holsboer F., and Michaelidis T.M. Subtle shifts in the ratio between pro- and antiapoptotic molecules after activation of corticosteroid receptors decide neuronal fate. FASEB J. 14 (2000) 779-790
2. Banasiak K.J., Cronin T., and Haddad G.G. Bcl-2 prolongs neuronal survival during hypoxia-induced apoptosis. Brain Res. Mol. Brain Res. 72 (1999) 214-225
3. Belcredito S., Vegeto E., Brusadelli A., Ghisletti S., Mussi P., Ciana P., and Maggi A. Estrogen neuroprotection: the involvement of the Bcl-2 binding protein BNIP2. Brain Res. Brain Res. Rev. 37 (2001) 335-342
4. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
5. Brinton R.D. Requirements of a brain selective estrogen: advances and remaining challenges for developing a NeuroSERM. J. Alzheimer's Dis. 6 (2004) S27-S35
6. Chen J., Graham S.H., Nakayama M., Zhu R.L., Jin K., Stetler R.A., and Simon R.P. Apoptosis repressor genes Bcl-2 and Bcl-x-long are expressed in the rat brain following global ischemia. J. Cereb. Blood Flow Metab. 17 (1997) 2-10
7. Choi Y.C., Lee J.H., Hong K.W., and Lee K.S. 17 Beta-estradiol prevents focal cerebral ischemic damages via activation of Akt and CREB in association with reduced PTEN phosphorylation in rats. Fundam. Clin. Pharmacol. 18 (2004) 547-557
8. Dhandapani K.M., and Brann D.W. Protective effects of estrogen and selective estrogen receptor modulators in the brain. Biol. Reprod. 67 (2002) 1379-1385
9. Dhandapani K.M., Wade F.M., Mahesh V.B., and Brann D.W. Astrocyte-derived transforming growth factor-{beta} mediates the neuroprotective effects of 17{beta}-estradiol: involvement of nonclassical genomic signaling pathways. Endocrinology 146 (2005) 2749-2759
10. Dubal D.B., Kashon M.L., Pettigrew L.C., Ren J.M., Finklestein S.P., Rau S.W., and Wise P.M. Estradiol protects against ischemic injury. J. Cereb. Blood Flow Metab. 18 (1998) 1253-1258
11. Dubal D.B., Shughrue P.J., Wilson M.E., Merchenthaler I., and Wise P.M. Estradiol modulates bcl-2 in cerebral ischemia: a potential role for estrogen receptors. J. Neurosci. 19 (1999) 6385-6393
12. Dubal D.B., Wilson M.E., and Wise P.M. Estradiol: a protective and trophic factor in the brain. J. Alzheimer's Dis. 1 (1999) 265-274
13. Dubal D.B., Rau S.W., Shughrue P.J., Zhu H., Yu J., Cashion A.B., Suzuki S., Gerhold L.M., Bottner M.B., Dubal S.B., Merchanthaler I., Kindy M.S., and Wise P.M. Differential modulation of estrogen receptors (ERs) in ischemic brain injury: a role for ERalpha in estradiol-mediated protection against delayed cell death. Endocrinology 147 (2006) 3076-3084
14. Dutertre M., and Smith C.L. Molecular mechanisms of selective estrogen receptor modulator (SERM) action. J. Pharmacol. Exp. Ther. 295 (2000) 431-437
15. Eberling J.L. Oestrogen has neuroprotective effects and may reduce the risk of Alzheimer's disease. Expert Opin. Biol. Ther. 2 (2002) 647-657
16. Garcia-Segura L.M., Cardona-Gomez P., Naftolin F., and Chowen J.A. Estradiol upregulates Bcl-2 expression in adult brain neurons. Neuroreport 9 (1998) 593-597
17. Garcia-Segura L.M., Azcoitia I., and DonCarlos L.L. Neuroprotection by estradiol. Prog. Neurobiol. 63 (2001) 29-60
18. Gohel A., McCarthy M.B., and Gronowicz G. Estrogen prevents glucocorticoid-induced apoptosis in osteoblasts in vivo and in vitro. Endocrinology 140 (1999) 5339-5347
19. Graham S.H., Chen J., and Clark R.S. Bcl-2 family gene products in cerebral ischemia and traumatic brain injury. J. Neurotrauma. 17 (2000) 831-841
20. Green P.S., and Simpkins J.W. Neuroprotective effects of estrogens: potential mechanisms of action. Int. J. Dev. Neurosci. 18 (2000) 347-358
21. Gross A., Jockel J., Wei M.C., and Korsmeyer S.J. Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis. EMBO J. 17 (1998) 3878-3885
22. Haldar S., Jena N., and Croce C. Inactivation of Bcl-2 by phosphorylation. Proc. Natl. Acad. Sci. 92 (1995) 4507-4511
23. Hall E.D., Pazara K.E., and Linseman K.L. Sex differences in postischemic neuronal necrosis in gerbils. J. Cereb. Blood Flow Metab. 11 (1991) 292-298
24. Harms C., Lautenschlager M., Bergk A., Katchanov J., Freyer D., Kapinya K., Herwig U., Megow D., Dirnagl U., Weber J.R., and Hortnagl H. Differential mechanisms of neuroprotection by 17 beta-estradiol in apoptotic versus necrotic neurodegeneration. J. Neurosci. 21 (2001) 2600-2609
25. Heaton M.B., Moore D.B., Paiva M., Gibbs T., and Bernard O. Bcl-2 overexpression protects the neonatal cerebellum from ethanol neurotoxicity. Brain Res. 817 (1999) 13-18
26. Inoue M., Nakamura K., Iwahashi K., Ameno K., Itoh M., and Suwaki H. Changes of bcl-2 and bax mRNA expressions in the ethanol-treated mouse brain. Nihon Arukoru Yakubutsu Igakkai Zasshi 37 (2002) 120-129
27. Jarskog L.F., Selinger E.S., Lieberman J.A., and Gilmore J.H. Apoptotic proteins in the temporal cortex in schizophrenia: high Bax/Bcl-2 ratio without caspase-3 activation. Am. J. Psychiatry 161 (2004) 109-115
28. Jover T., Tanaka H., Calderone A., Oguro K., Bennett M.V., Etgen A.M., and Zukin R.S. Estrogen protects against global ischemia-induced neuronal death and prevents activation of apoptotic signaling cascades in the hippocampal CA1. J. Neurosci. 22 (2002) 2115-2124
29. Kendall W., and Brown P. Is low-dose tamoxifen useful for the treatment and prevention of breast cancer?. J. Natl. Cancer Inst. 95 (2003) 766-767
30. Korsmeyer S.J., Shutter J.R., Veis D.J., Merry D.E., and Oltvai Z.N. Bcl-2/Bax: a rheostat that regulates an anti-oxidant pathway and cell death. Semin. Cancer Biol. 4 (1993) 327-332
31. Leung L.K., and Wang T.T. Paradoxical regulation of Bcl-2 family proteins by 17beta-oestradiol in human breast cancer cells MCF-7. Br. J. Cancer 81 (1999) 387-392
32. Liu R., Yang S.H., Perez E., Yi K.D., Wu S.S., Eberst K., Prokai L., Prokai-Tatrai K., Cai Z.Y., Covey D.F., Day A.L., and Simpkins J.W. Neuroprotective effects of a novel non-receptor-binding estrogen analogue: in vitro and in vivo analysis. Stroke 33 (2002) 2485-2491
33. Lu Y.P., Zeng M., Hu X.Y., Xu H., Swaab D.F., Ravid R., and Zhou J.N. Estrogen receptor alpha-immunoreactive astrocytes are increased in the hippocampus in Alzheimer's disease. Exp. Neurol. 183 (2003) 482-488
34. McEwen B.S. Invited review: estrogens effects on the brain: multiple sites and molecular mechanisms. J. Appl. Physiol. 91 (2001) 2785-2801
35. McEwen B. Estrogen actions throughout the brain. Recent Prog. Horm. Res. 57 (2002) 357-384
36. Mehra R.D., Sharma K., Nyakas C., and Vij U. Estrogen receptor alpha and beta immunoreactive neurons in normal adult and aged female rat hippocampus: a qualitative and quantitative study. Brain Res. 1056 (2005) 22-35
37. Mize A.L., Shapiro R.A., and Dorsa D.M. Estrogen receptor-mediated neuroprotection from oxidative stress requires activation of the mitogen-activated protein kinase pathway. Endocrinology 144 (2003) 306-312
38. Oltvai Z.N., Milliman C.L., and Korsmeyer S.J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74 (1993) 609-619
39. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (1997), Academic Press, New York Paper Back
40. Phillis J.W., Song D., and O'Regan M.H. Tamoxifen, a chloride channel blocker, reduces glutamate and aspartate release from the ischemic cerebral cortex. Brain Res. 780 (1998) 352-355
41. Priest C.A., and Roberts J.L. Estrogen and tamoxifen differentially regulate beta-endorphin and cFos expression and neuronal colocalization in the arcuate nucleus of the rat. Neuroendocrinology 72 (2000) 293-305
42. Rau S.W., Dubal D.B., Bottner M., Gerhold L.M., and Wise P.M. Estradiol attenuates programmed cell death after stroke-like injury. J. Neurosci. 23 (2003) 11420-11426
43. Sato M., Glasebrook A.L., and Bryant H.U. Raloxifene: a selective estrogen receptor modulator. J. Bone Miner. Metab. 12 Suppl 2 (1994) S9-S20
44. Sharma K., Mehra R.D., Dhar P., and Vij U. Chronic exposure to estrogen and tamoxifen regulates synaptophysin and phosphorylated cAMP response element-binding (CREB) protein expression in CA1 of ovariectomized rat hippocampus. Brain Res. 1132 (2007) 10-19
45. Sherwin B.B. Estrogen and cognitive functioning in women. Proc. Soc. Exp. Biol. Med. 217 (1998) 17-22
46. Sherwin B.B. Estrogen and cognitive aging in women. Neuroscience 138 (2006) 1021-1026
47. Shughrue P.J., and Merchenthaler I. Estrogen prevents the loss of CA1 hippocampal neurons in gerbils after ischemic injury. Neuroscience 116 (2003) 851-861
48. Singer C.A., Rogers K.L., and Dorsa D.M. Modulation of Bcl-2 expression: a potential component of estrogen protection in NT2 neurons. Neuroreport 9 (1998) 2565-2568
49. Smith Y.R., Giordani B., Lajiness-O'Neill R., and Zubieta J.K. Long-term estrogen replacement is associated with improved nonverbal memory and attentional measures in postmenopausal women. Fertil. Steril. 76 (2001) 1101-1107
50. Sribnick E.A., Ray S.K., Nowak M.W., Li L., and Banik N.L. 17beta-estradiol attenuates glutamate-induced apoptosis and preserves electrophysiologic function in primary cortical neurons. J. Neurosci. Res. 76 (2004) 688-696
51. Tamatani M., Che Y.H., Matsuzaki H., Ogawa S., Okado H., Miyake S., Mizuno T., and Tohyama M. Tumor necrosis factor induces Bcl-2 and Bcl-x expression through NFkappaB activation in primary hippocampal neurons. J. Biol. Chem. 274 (1999) 8531-8538
52. Tosoni A., Ermani M., and Brandes A.A. The pathogenesis and treatment of brain metastases: a comprehensive review. Crit. Rev. Oncol. Hematol. 52 (2004) 199-215
53. Veliskova J., Velisek L., Galanopoulou A.S., and Sperber E.F. Neuroprotective effects of estrogens on hippocampal cells in adult female rats after status epilepticus. Epilepsia 41 Suppl 6 (2000) S30-S35
54. Wagner C.K., Silverman A.J., and Morrell J.I. Evidence for estrogen receptor in cell nuclei and axon terminals within the lateral habenula of the rat: regulation during pregnancy. J. Comp. Neurol. 392 (1998) 330-342
55. Wilson M.E., Dubal D.B., and Wise P.M. Estradiol protects against injury-induced cell death in cortical explant cultures: a role for estrogen receptors. Brain Res. 873 (2000) 235-242
56. Wisniewski A.B., Nguyen T.T., and Dobs A.S. Evaluation of high-dose estrogen and high-dose estrogen plus methyltestosterone treatment on cognitive task performance in postmenopausal women. Horm. Res. 58 (2002) 150-155
57. Woolley C.S., and McEwen B.S. Roles of estradiol and progesterone in regulation of hippocampal dendritic spine density during the estrous cycle in the rat. J. Comp. Neurol. 336 (1993) 293-306
58. Woolley C.S., Wenzel H.J., and Schwartzkroin P.A. Estradiol increases the frequency of multiple synapse boutons in the hippocampal CA1 region of the adult female rat. J. Comp. Neurol. 373 (1996) 108-117
59. Wu K., and Brown P. Is low-dose tamoxifen useful for the treatment and prevention of breast cancer?. J. Natl. Cancer Inst. 95 (2003) 766-767
60. Yao M., Nguyen T.V., and Pike C.J. Estrogen regulates Bcl-w and Bim expression: role in protection against beta-amyloid peptide-induced neuronal death. J. Neurosci. 27 (2007) 1422-1433
61. Zhang Y., Lu X., and Bhavnani B.R. Equine estrogens differentially inhibit DNA fragmentation induced by glutamate in neuronal cells by modulation of regulatory proteins involved in programmed cell death. BMC Neurosci. 4 (2003) 32
62. Zhang T.J., Hang J., Wen D.X., Hang Y.N., and Sieber F.E. Hippocampus bcl-2 and bax expression and neuronal apoptosis after moderate hypothermic cardiopulmonary bypass in rats. Anesth. Analg. 102 (2006) 1018-1025
63. Zhao H., Yenari M.A., Cheng D., Sapolsky R.M., and Steinberg G.K. Bcl-2 overexpression protects against neuron loss within the ischemic margin following experimental stroke and inhibits cytochrome c translocation and caspase-3 activity. J. Neurochem. 85 (2003) 1026-1036
64. Zhao L., Wu T.W., and Brinton R.D. Estrogen receptor subtypes alpha and beta contribute to neuroprotection and increased Bcl-2 expression in primary hippocampal neurons. Brain Res. 1010 (2004) 22-34
65. Zhou W., Koldzic-Zivanovic N., Clarke C.H., de Beun R., Wassermann K., Bury P.S., Cunningham K.A., and Thomas M.L. Selective estrogen receptor modulator effects in the rat brain. Neuroendocrinology 75 (2002) 24-33
66. Znamensky V., Akama K.T., McEwen B.S., and Milner T.A. Estrogen levels regulate the subcellular distribution of phosphorylated Akt in hippocampal CA1 dendrites. J. Neurosci. 23 (2003) 2340-2347